Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chugai Pharmaceutical | Tokyo | Salute | Prodotti farmaceutici | 11,88 Bln JPY | 33,5x | 3,7 | 7.339 JPY | 2,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -9% Ribasso | Fai l’upgrade a Pro+ | |
Daiichi Sankyo | Tokyo | Salute | Prodotti farmaceutici | 9,3 Bln JPY | 40,5x | 0,74 | 4.867 JPY | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 33,9% Rialzo | Fai l’upgrade a Pro+ | |
Takeda Pharmaceutical | Tokyo | Salute | Prodotti farmaceutici | 6,58 Bln JPY | 43,5x | -0,89 | 4.163 JPY | -1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,5% Rialzo | Fai l’upgrade a Pro+ | |
Otsuka Holdings Ltd | Tokyo | Salute | Prodotti farmaceutici | 4,45 Bln JPY | 35,2x | -1,41 | 8.271 JPY | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8% Rialzo | Fai l’upgrade a Pro+ | |
Astellas Pharma Inc. | Tokyo | Salute | Prodotti farmaceutici | 3,04 Bln JPY | 141,1x | -1,82 | 1.709,50 JPY | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,3% Rialzo | Fai l’upgrade a Pro+ | |
Shionogi | Tokyo | Salute | Prodotti farmaceutici | 1,81 Bln JPY | 4,1x | -0,61 | 2.137,50 JPY | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,2% Rialzo | Fai l’upgrade a Pro+ | |
Eisai | Tokyo | Salute | Prodotti farmaceutici | 1,56 Bln JPY | 48,5x | -1,5 | 5.525 JPY | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 33,2% Rialzo | Fai l’upgrade a Pro+ | |
Kyowa Kirin | Tokyo | Salute | Prodotti farmaceutici | 1,34 Bln JPY | 14,1x | 0,12 | 2.572,50 JPY | -1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 34,9% Rialzo | Fai l’upgrade a Pro+ | |
Ono Pharmaceutical Ltd | Tokyo | Salute | Prodotti farmaceutici | 910,64 Mrd JPY | 7,6x | 0,96 | 1.943 JPY | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,9% Rialzo | Fai l’upgrade a Pro+ | |
Rohto Pharmaceutical | Tokyo | Salute | Prodotti farmaceutici | 831,79 Mrd JPY | 27,6x | 4,04 | 3.669 JPY | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8% Rialzo | Fai l’upgrade a Pro+ | |
Santen Pharmaceutical Co Ltd | Tokyo | Salute | Prodotti farmaceutici | 624,29 Mrd JPY | 24,3x | 0,07 | 1.788,50 JPY | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,5% Rialzo | Fai l’upgrade a Pro+ | |
Medipal Holdings Corp | Tokyo | Salute | Prodotti farmaceutici | 526,33 Mrd JPY | 13,6x | -3,11 | 2.530,50 JPY | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -4,2% Ribasso | Fai l’upgrade a Pro+ | |
Suzuken Co Ltd | Tokyo | Salute | Prodotti farmaceutici | 393,95 Mrd JPY | 13,3x | 0,23 | 5.084 JPY | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -1,1% Ribasso | Fai l’upgrade a Pro+ | |
Tsumura & Co | Tokyo | Salute | Prodotti farmaceutici | 338,56 Mrd JPY | 14,3x | 0,19 | 4.471 JPY | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,2% Rialzo | Fai l’upgrade a Pro+ | |
Toho Holdings | Tokyo | Salute | Prodotti farmaceutici | 291,42 Mrd JPY | 14,1x | 0,21 | 4.650 JPY | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -18% Ribasso | Fai l’upgrade a Pro+ | |
Hisamitsu Pharmaceutical Inc | Tokyo | Salute | Prodotti farmaceutici | 290,66 Mrd JPY | 20,6x | 2,64 | 3.960 JPY | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8,5% Rialzo | Fai l’upgrade a Pro+ | |
Sawai Group Holdings Co | Tokyo | Salute | Prodotti farmaceutici | 259,51 Mrd JPY | 3,6x | 0,21 | 2.078,50 JPY | -2,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 12,1% Rialzo | Fai l’upgrade a Pro+ | |
Nippon Shinyaku | Tokyo | Salute | Prodotti farmaceutici | 256,14 Mrd JPY | 9,4x | 0,48 | 3.815 JPY | -2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -11,7% Ribasso | Fai l’upgrade a Pro+ | |
Sumitomo Dainippon Pharma | Tokyo | Salute | Prodotti farmaceutici | 240,36 Mrd JPY | -0,9x | 0,01 | 609 JPY | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -21,4% Ribasso | Fai l’upgrade a Pro+ | |
Kissei Pharmaceutical | Tokyo | Salute | Prodotti farmaceutici | 158,25 Mrd JPY | 13,4x | 8,32 | 3.570 JPY | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 6,5% Rialzo | Fai l’upgrade a Pro+ | |
Kaken Pharmaceutical Co Ltd | Tokyo | Salute | Prodotti farmaceutici | 151,74 Mrd JPY | 20,1x | 0,48 | 3.849 JPY | -3,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -10,2% Ribasso | Fai l’upgrade a Pro+ | |
Towa Pharmaceutical | Tokyo | Salute | Prodotti farmaceutici | 150,61 Mrd JPY | 8,9x | 0,04 | 3.065 JPY | -1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20% Rialzo | Fai l’upgrade a Pro+ | |
Mochida Pharmaceutical | Tokyo | Salute | Prodotti farmaceutici | 121,78 Mrd JPY | 27,8x | -2,25 | 3.430 JPY | -2,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -9,3% Ribasso | Fai l’upgrade a Pro+ | |
Nxera Pharma | Tokyo | Salute | Prodotti farmaceutici | 115,97 Mrd JPY | -11,4x | 0,02 | 1.297 JPY | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 49,1% Rialzo | Fai l’upgrade a Pro+ | |
Torii Pharmaceutical | Tokyo | Salute | Prodotti farmaceutici | 109,34 Mrd JPY | 20,9x | 0,31 | 3.900 JPY | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,1% Rialzo | Fai l’upgrade a Pro+ | |
Zeria Pharmaceutical | Tokyo | Salute | Prodotti farmaceutici | 99,53 Mrd JPY | 11,1x | 0,28 | 2.256 JPY | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 40,1% Rialzo | Fai l’upgrade a Pro+ | |
Kyorin Holdings Inc | Tokyo | Salute | Prodotti farmaceutici | 88,18 Mrd JPY | 16x | 0,51 | 1.532 JPY | -1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -16,8% Ribasso | Fai l’upgrade a Pro+ | |
JCR Pharmaceuticals | Tokyo | Salute | Prodotti farmaceutici | 84,76 Mrd JPY | 20,7x | 10,35 | 680 JPY | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -11,8% Ribasso | Fai l’upgrade a Pro+ | |
Katakura Industries | Tokyo | Salute | Prodotti farmaceutici | 67,57 Mrd JPY | 23,9x | -2,82 | 2.085 JPY | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ASKA Pharmaceutical Holdings Co | Tokyo | Salute | Prodotti farmaceutici | 64,22 Mrd JPY | 8,7x | 0,12 | 2.255 JPY | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,8% Rialzo | Fai l’upgrade a Pro+ |